EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Seroprevalence of Protective Antibodies Against Influenza and the Reduction of the Influenza Incidence Rate: An Annual Repeated Cross‐Sectional Study From 2014 to 2019

Raquel Guiomar iD, Susana Pereira da Silva, Inês Costa, Patricia Conde, Paula Cristóvão, Ana Paula Rodrigues, Aida Fernandes, Ana Paula Dias, Ana Rita Couto, Angélica Ramos, Carina Moita, Carina Rodrigues und 29 weitere

Influenza and Other Respiratory Viruses · 2024-05 · 18 (5)

DOI: 10.1111/irv.13307 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Influenza and Other Respiratory Viruses, online erschienen am 26.05.2024. Verfasst von Raquel Guiomar und 40 weiteren Autor:innen. Beteiligte Einrichtung: National Reference Laboratory for Influenza and Other Respiratory Viruses, Infectious Diseases Department, National Institute of Health Dr. Ricardo J…. Hauptthemen laut MEDLINE: Influenza, Human, Antibodies, Viral. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 37 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Institute of Health Doctor Ricardo Jorge, IP.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Seroepidemiological studies provide estimates of population‐level immunity, prevalence/incidence of infections, and evaluation of vaccination programs. We assessed the seroprevalence of protective antibodies against influenza and evaluated the correlation of seroprevalence with the cumulative annual influenza incidence rate.

Methods

We conducted an annual repeated cross‐sectional seroepidemiological survey, during June–August, from 2014 to 2019, in Portugal. A total of 4326 sera from all age groups, sex, and regions was tested by hemagglutination inhibition assay. Seroprevalence and geometric mean titers (GMT) of protective antibodies against influenza were assessed by age group, sex, and vaccine status (65+ years old). The association between summer annual seroprevalence and the difference of influenza incidence rates between one season and the previous one was measured by Pearson correlation coefficient ( r ).

Results

Significant differences in seroprevalence of protective antibodies against influenza were observed in the population. Higher seroprevalence and GMT for A(H1N1)pdm09 and A(H3N2) were observed in children (5–14); influenza B seroprevalence in adults 65+ was 1.6–4.4 times than in children (0–4). Vaccinated participants (65+) showed significant higher seroprevalence/GMT for influenza. A strong negative and significant correlation was found between seroprevalence and ILI incidence rate for A(H1N1)pdm09 in children between 5 and 14 ( r = −0.84; 95% CI, −0.98 to −0.07); a weak negative correlation was observed for A(H3N2) and B/Yamagata ( r ≤ −0.1).

Conclusions

The study provides new insight into the anti‐influenza antibodies seroprevalence measured in summer on the ILI incidence rate in the next season and the need for adjusted preventive health care measures to prevent influenza infection and transmission.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Influenza, HumanAntibodies, ViralHumansSeroepidemiologic StudiesCross-Sectional StudiesFemaleMaleAdultIncidenceChild, PreschoolChildMiddle AgedAdolescentYoung AdultAgedPortugalInfantInfluenza VaccinesInfluenza A Virus, H1N1 SubtypeInfluenza A Virus, H3N2 SubtypeHemagglutination Inhibition TestsInfluenza B virus

Stichwörter der Autor:innen

ILI incidence rateantibodiesinfluenzaseroprevalence

Substanzen

Antibodies, ViralInfluenza Vaccines

Autor:innen und Institutionen

  • National Reference Laboratory for Influenza and Other Respiratory Viruses, Infectious Diseases Department, National Institute of Health Dr. Ricardo Jorge, IP, Lisbon, Portugal.
  • Department of Epidemiology, National Institute of Health Dr. Ricardo Jorge, IP, Lisbon, Portugal.
  • Laboratório de Saúde Pública Dr.ª Laura Ayres, Faro, Portugal.
  • Centro Hospitalar de Lisboa Ocidental, E. P. E., Lisbon, Portugal.
  • Hospital de Santo Espírito da Ilha Terceira, E. P. E.R., Angra do Heroísmo, Portugal.
  • Centro Hospitalar Universitário de São João, E. P. E., Porto, Portugal.

ORCID-Profile: Raquel Guiomar, Luisa Mota-Vieira

Förderung

  • National Institute of Health Doctor Ricardo Jorge, IP

Zitieren

APA

Guiomar, R., Pereira da Silva, S., Costa, I., Conde, P., Cristóvão, P., Rodrigues, A. P., Fernandes, A., Dias, A. P., Couto, A. R., Ramos, A., Moita, C., Rodrigues, C., Vale, F., Caldeira, F., Bruges Armas, J., Pereira-Vaz, J., Alves, J., Freitas, L., Martins, L., …, & Nunes, B. (2024). Seroprevalence of Protective Antibodies Against Influenza and the Reduction of the Influenza Incidence Rate: An Annual Repeated Cross‐Sectional Study From 2014 to 2019. Influenza and Other Respiratory Viruses, 18(5). https://doi.org/10.1111/irv.13307

Vancouver

Guiomar R, Pereira da Silva S, Costa I, Conde P, Cristóvão P, Rodrigues AP, et al. Seroprevalence of Protective Antibodies Against Influenza and the Reduction of the Influenza Incidence Rate: An Annual Repeated Cross‐Sectional Study From 2014 to 2019. Influenza and Other Respiratory Viruses. 2024;18(5). doi:10.1111/irv.13307

BibTeX
@article{Guiomar2024,
  author = {Guiomar, Raquel and Pereira da Silva, Susana and Costa, Inês and Conde, Patricia and Cristóvão, Paula and Rodrigues, Ana Paula and Fernandes, Aida and Dias, Ana Paula and Couto, Ana Rita and Ramos, Angélica and Moita, Carina and Rodrigues, Carina and Vale, Fátima and Caldeira, Filomena and Bruges Armas, Jácome and Pereira-Vaz, João and Alves, José and Freitas, Ludivina and Martins, Luis and Milho, Luís and Mota-Vieira, Luisa and Lopes, Lurdes and Freitas, Margarida and Pessanha, Maria Ana and Correia, Maria and Marques, Maria Helena and Cardoso, Maria João and Peres, Maria João and Cunha, Mário and Amantegui, Patricia and Mota, Paula and Lopes, Paulo and Pereira, Paulo and Viseu, Regina and Cabral, Rita and Côrte-Real, Rita and Almeida, Sofia and Soares, Vânia and Mansinho, Kamal and Hungnes, Olav and Nunes, Baltazar},
  title = {Seroprevalence of Protective Antibodies Against Influenza and the Reduction of the Influenza Incidence Rate: An Annual Repeated Cross‐Sectional Study From 2014 to 2019},
  journal = {Influenza and Other Respiratory Viruses},
  year = {2024},
  volume = {18},
  number = {5},
  doi = {10.1111/irv.13307}
}
Kostenlos starten →